Laronde develops an eRNA-based therapeutic platform that is capable of indicating diverse proteins inside the body.
Sign up today and learn more about Laronde Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Laronde Stock
Laronde develops an eRNA-based therapeutic platform that is capable of indicating diverse proteins inside the body. It is persistent, non-immunogenic, allows for repeat dosing, and offers flexibility in formulation and delivery. Laronde was founded in 2017 by Flagship Labs, the innovation foundry of Flagship Pioneering. The company is rapidly scaling to support the parallel development of multiple programs across many disease areas.
Co-founder and Chairman of the Board
Co-founder & Board of Directors
Board of Directors
Chief Operating Officer
Chief Technology Officer
Head of Manufacturing
Chief Scientific Officer